473 related articles for article (PubMed ID: 30509319)
1. Comprehensive methylation analysis of imprinting-associated differentially methylated regions in colorectal cancer.
Hidaka H; Higashimoto K; Aoki S; Mishima H; Hayashida C; Maeda T; Koga Y; Yatsuki H; Joh K; Noshiro H; Iwakiri R; Kawaguchi A; Yoshiura KI; Fujimoto K; Soejima H
Clin Epigenetics; 2018 Dec; 10(1):150. PubMed ID: 30509319
[TBL] [Abstract][Full Text] [Related]
2. IGF2 differentially methylated region hypomethylation in relation to pathological and molecular features of serrated lesions.
Naito T; Nosho K; Ito M; Igarashi H; Mitsuhashi K; Yoshii S; Aoki H; Nomura M; Sukawa Y; Yamamoto E; Adachi Y; Takahashi H; Hosokawa M; Fujita M; Takenouchi T; Maruyama R; Suzuki H; Baba Y; Imai K; Yamamoto H; Ogino S; Shinomura Y
World J Gastroenterol; 2014 Aug; 20(29):10050-61. PubMed ID: 25110432
[TBL] [Abstract][Full Text] [Related]
3. Hypomethylation of the IGF2 DMR in colorectal tumors, detected by bisulfite pyrosequencing, is associated with poor prognosis.
Baba Y; Nosho K; Shima K; Huttenhower C; Tanaka N; Hazra A; Giovannucci EL; Fuchs CS; Ogino S
Gastroenterology; 2010 Dec; 139(6):1855-64. PubMed ID: 20682317
[TBL] [Abstract][Full Text] [Related]
4. IGF2 DMR0 methylation, loss of imprinting, and patient prognosis in esophageal squamous cell carcinoma.
Murata A; Baba Y; Watanabe M; Shigaki H; Miyake K; Ishimoto T; Iwatsuki M; Iwagami S; Yoshida N; Oki E; Morita M; Nakao M; Baba H
Ann Surg Oncol; 2014 Apr; 21(4):1166-74. PubMed ID: 24318096
[TBL] [Abstract][Full Text] [Related]
5. Loss of imprinting of IGF2 correlates with hypomethylation of the H19 differentially methylated region in the tumor tissue of colorectal cancer patients.
Tian F; Tang Z; Song G; Pan Y; He B; Bao Q; Wang S
Mol Med Rep; 2012 Jun; 5(6):1536-40. PubMed ID: 22427002
[TBL] [Abstract][Full Text] [Related]
6. Mutations in both KRAS and BRAF may contribute to the methylator phenotype in colon cancer.
Nagasaka T; Koi M; Kloor M; Gebert J; Vilkin A; Nishida N; Shin SK; Sasamoto H; Tanaka N; Matsubara N; Boland CR; Goel A
Gastroenterology; 2008 Jun; 134(7):1950-60, 1960.e1. PubMed ID: 18435933
[TBL] [Abstract][Full Text] [Related]
7. Clinicopathological features of CpG island methylator phenotype-positive colorectal cancer and its adverse prognosis in relation to KRAS/BRAF mutation.
Lee S; Cho NY; Choi M; Yoo EJ; Kim JH; Kang GH
Pathol Int; 2008 Feb; 58(2):104-13. PubMed ID: 18199160
[TBL] [Abstract][Full Text] [Related]
8. Loss of imprinting and marked gene elevation are 2 forms of aberrant IGF2 expression in colorectal cancer.
Cheng YW; Idrees K; Shattock R; Khan SA; Zeng Z; Brennan CW; Paty P; Barany F
Int J Cancer; 2010 Aug; 127(3):568-77. PubMed ID: 19957330
[TBL] [Abstract][Full Text] [Related]
9. TGFBR2 mutation is correlated with CpG island methylator phenotype in microsatellite instability-high colorectal cancer.
Ogino S; Kawasaki T; Ogawa A; Kirkner GJ; Loda M; Fuchs CS
Hum Pathol; 2007 Apr; 38(4):614-20. PubMed ID: 17270239
[TBL] [Abstract][Full Text] [Related]
10. Loss of imprinting in colorectal cancer linked to hypomethylation of H19 and IGF2.
Cui H; Onyango P; Brandenburg S; Wu Y; Hsieh CL; Feinberg AP
Cancer Res; 2002 Nov; 62(22):6442-6. PubMed ID: 12438232
[TBL] [Abstract][Full Text] [Related]
11. Down-regulation of p21 (CDKN1A/CIP1) is inversely associated with microsatellite instability and CpG island methylator phenotype (CIMP) in colorectal cancer.
Ogino S; Kawasaki T; Kirkner GJ; Ogawa A; Dorfman I; Loda M; Fuchs CS
J Pathol; 2006 Oct; 210(2):147-54. PubMed ID: 16850502
[TBL] [Abstract][Full Text] [Related]
12. Frequent aberrant methylation of the imprinted IGF2/H19 locus and LINE1 hypomethylation in ovarian carcinoma.
Dammann RH; Kirsch S; Schagdarsurengin U; Dansranjavin T; Gradhand E; Schmitt WD; Hauptmann S
Int J Oncol; 2010 Jan; 36(1):171-9. PubMed ID: 19956846
[TBL] [Abstract][Full Text] [Related]
13. Novel application of structural equation modeling to correlation structure analysis of CpG island methylation in colorectal cancer.
Tanaka N; Huttenhower C; Nosho K; Baba Y; Shima K; Quackenbush J; Haigis KM; Giovannucci E; Fuchs CS; Ogino S
Am J Pathol; 2010 Dec; 177(6):2731-40. PubMed ID: 21037082
[TBL] [Abstract][Full Text] [Related]
14. Comprehensive profiling of DNA methylation in colorectal cancer reveals subgroups with distinct clinicopathological and molecular features.
Ang PW; Loh M; Liem N; Lim PL; Grieu F; Vaithilingam A; Platell C; Yong WP; Iacopetta B; Soong R
BMC Cancer; 2010 May; 10():227. PubMed ID: 20492682
[TBL] [Abstract][Full Text] [Related]
15. Distinct features between MLH1-methylated and unmethylated colorectal carcinomas with the CpG island methylator phenotype: implications in the serrated neoplasia pathway.
Kim JH; Bae JM; Cho NY; Kang GH
Oncotarget; 2016 Mar; 7(12):14095-111. PubMed ID: 26883113
[TBL] [Abstract][Full Text] [Related]
16. Loss of imprinting of IGF2 and H19 in osteosarcoma is accompanied by reciprocal methylation changes of a CTCF-binding site.
Ulaner GA; Vu TH; Li T; Hu JF; Yao XM; Yang Y; Gorlick R; Meyers P; Healey J; Ladanyi M; Hoffman AR
Hum Mol Genet; 2003 Mar; 12(5):535-49. PubMed ID: 12588801
[TBL] [Abstract][Full Text] [Related]
17. Epigenetic specificity of loss of imprinting of the IGF2 gene in Wilms tumors.
Bjornsson HT; Brown LJ; Fallin MD; Rongione MA; Bibikova M; Wickham E; Fan JB; Feinberg AP
J Natl Cancer Inst; 2007 Aug; 99(16):1270-3. PubMed ID: 17686827
[TBL] [Abstract][Full Text] [Related]
18. Loss of Igf2 imprinting in monoclonal mouse hepatic tumor cells is not associated with abnormal methylation patterns for the H19, Igf2, and Kvlqt1 differentially methylated regions.
Ishizaki T; Yoshie M; Yaginuma Y; Tanaka T; Ogawa K
J Biol Chem; 2003 Feb; 278(8):6222-8. PubMed ID: 12475990
[TBL] [Abstract][Full Text] [Related]
19. Relationship of porcine IGF2 imprinting status to DNA methylation at the H19 DMD and the IGF2 DMRs 1 and 2.
Braunschweig MH; Owczarek-Lipska M; Stahlberger-Saitbekova N
BMC Genet; 2011 May; 12():47. PubMed ID: 21575277
[TBL] [Abstract][Full Text] [Related]
20. LINE-1 hypomethylation is inversely associated with microsatellite instability and CpG island methylator phenotype in colorectal cancer.
Ogino S; Kawasaki T; Nosho K; Ohnishi M; Suemoto Y; Kirkner GJ; Fuchs CS
Int J Cancer; 2008 Jun; 122(12):2767-73. PubMed ID: 18366060
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
